One preclinical study implicated p110δ in PTEN-deficient T-cell ALL, and utilized a murine model to demonstrate prolonged survival with dual inhibition of γ and δ isoforms [39]. This evidence concerns the gene PIK3CD and acute lymphoblastic leukemia.